Twist Bioscience Corp [TWST] stock is trading at $52.70, up 3.86%. An important factor to consider is whether the stock is rising or falling in short-term value. The TWST shares have gain 7.16% over the last week, with a monthly amount glided 16.03%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Twist Bioscience Corp [NASDAQ: TWST] stock has seen the most recent analyst activity on June 04, 2024, when Guggenheim initiated its Buy rating and assigned the stock a price target of $53. Previously, Goldman upgraded its rating to Buy on January 17, 2024, and elevated its price target to $45. On September 27, 2023, Berenberg initiated with a Buy rating and assigned a price target of $27 on the stock. Scotiabank started tracking the stock assigning a Sector Outperform rating and suggested a price target of $33 on January 05, 2023. Evercore ISI upgraded its rating to a Outperform and raised its price target to $36 on January 03, 2023.
Twist Bioscience Corp [TWST] stock has fluctuated between $24.60 and $60.90 over the past year. Currently, Wall Street analysts expect the stock to reach $46 within the next 12 months. Twist Bioscience Corp [NASDAQ: TWST] shares were valued at $52.70 at the most recent close of the market. An investor can expect a potential drop of -12.71% based on the average TWST price forecast.
Analyzing the TWST fundamentals
Twist Bioscience Corp [NASDAQ:TWST] reported sales of 312.97M for the trailing twelve months, which represents a growth of 26.53%. Gross Profit Margin for this corporation currently stands at 0.43% with Operating Profit Margin at -0.71%, Pretax Profit Margin comes in at -0.66%, and Net Profit Margin reading is -0.67%. To continue investigating profitability, this company’s Return on Assets is posted at -0.34, Equity is -0.39 and Total Capital is -0.41. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 51.56 points at the first support level, and at 50.41 for the second support level. However, for the 1st resistance point, the stock is sitting at 53.72, and for the 2nd resistance point, it is at 54.73.
Ratios To Look Out For
For context, Twist Bioscience Corp’s Current Ratio is 4.88. On the other hand, the Quick Ratio is 4.54, and the Cash Ratio is 3.19. Considering the valuation of this stock, the price to sales ratio is 10.38, the price to book ratio is 6.56.
Transactions by insiders
Recent insider trading involved Cho Dennis, Officer, that happened on Dec 06 ’24 when 367.0 shares were purchased. Officer, Green Paula completed a deal on Dec 06 ’24 to buy 860.0 shares. Meanwhile, Officer Leproust Emily M. bought 2216.0 shares on Dec 06 ’24.
